Compass Therapeutics, Inc. (CMPX)

1.11 -0.02 (-1.77%) USD  |  NASDAQ  |  Sep 28, 16:00
1.12 +0.01 (+0.90%) After-Hours: 04:25
More

Compass Therapeutics Cost of Goods Sold (% of Annual Revenues)

Cost of Goods Sold (% of Annual Revenues) Chart

View Cost of Goods Sold (% of Annual Revenues) for CMPX.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Cost of Goods Sold (% of Annual Revenues) Chart
Start Trial

Historical Cost of Goods Sold (% of Annual Revenues) Data

View and export this data back to 2024. Start Trial.
Date Value
December 31, 2024 --

Cost of Goods Sold Definition

Returns the Cost of Goods Sold (COGS) for the period and date(s) requested in local currency by default.

Read full definition.

Cost of Goods Sold (% of Annual Revenues) Range, Past 5 Years

View Cost of Goods Sold (% of Annual Revenues) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Cost of Goods Sold (% of Annual Revenues) Benchmarks

View Cost of Goods Sold (% of Annual Revenues) Benchmarks
Start Trial
Viking Therapeutics, Inc. --
Capricor Therapeutics, Inc. --
Ardelyx, Inc. Upgrade
Biomea Fusion, Inc. --
ARS Pharmaceuticals, Inc. Upgrade